Hazard Information | Back Directory | [Uses]
Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study[1][2]. | [References]
[1] Cho SK, et al. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus. Expert Opin Investig Drugs. 2023 May;32(5):345-353. DOI:10.1080/13543784.2023.2212154 [2] Litifilimab. IMGT/mAb-DB. |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 |
Website: |
www.biolabreagent.com/ |
Company Name: |
Cell Sciences
|
Tel: |
9785721070 |
Website: |
www.cellsciences.com |
|